GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » Net Issuance of Debt

Vytrus Biotech (XMAD:VYT) Net Issuance of Debt : €-0.35 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Vytrus Biotech's net issuance of debt for the six months ended in Jun. 2024 was €-0.15 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.35 Mil.

Vytrus Biotech Net Issuance of Debt Historical Data

The historical data trend for Vytrus Biotech's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech Net Issuance of Debt Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Debt
Get a 7-Day Free Trial - - -0.01 0.03 0.96

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 0.05 1.16 -0.20 -0.15

Vytrus Biotech Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Vytrus Biotech's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Vytrus Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » Net Issuance of Debt
Comparable Companies
XMAD:BST VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX SMMT RPRX OCSE:GMAB XKRX:196170 INCY HKSE:02269 INSM HKSE:01801 SHSE:603392
Traded in Other Exchanges
N/A
Address
Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221
Website
https://www.vytrus.com
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines